Name
OÜ RNAexact
Registry code
14009275
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
08.03.2016 (8)
Financial year
01.01-31.12
Capital
2 502.00 €
Activity
72111 - Research and experimental development on biotechnology
2 029 €
-127 €
-6%
-
4 998 €
0
Submitted
No tax arrears
-3%
-2%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Ana Rebane 11.08.1966 (58) | 33% - 834.00 EUR | Board member | Direct ownership | Founder |
| Margus Pooga 07.08.1957 (67) | 33% - 834.00 EUR | Board member | Direct ownership | Founder |
| Sven Parkel 29.01.1981 (43) | 33% - 834.00 EUR | Board member | Direct ownership | Founder |
| 2019 30.06.2020 | 2020 14.06.2021 | 2021 08.03.2022 | 2022 07.04.2023 | 2023 14.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 5 936 € | 6 487 € | 4 954 € | 2 930 € | 2 029 € |
| Net profit (loss) for the period | 1 376 € | 232 € | 10 € | -569 € | -127 € |
| Profit Margin | 23% | 4% | 0% | -19% | -6% |
| Current Assets | 6 546 € | 7 582 € | 7 862 € | 6 067 € | 5 499 € |
| Fixed Assets | 912 € | 547 € | 182 € | 0 € | 0 € |
| Total Assets | 7 458 € | 8 129 € | 8 044 € | 6 067 € | 5 499 € |
| Current Liabilities | 2 005 € | 2 445 € | 2 349 € | 941 € | 501 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 5 453 € | 5 684 € | 5 695 € | 5 126 € | 4 998 € |
| Employees | 0 | 0 | 0 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2023 Q2 | 3 490.68 € | 336.8 € | - | - |
| 2023 Q1 | 2 562.52 € | 400.5 € | - | - |
| 2022 Q4 | 818 € | 45.5 € | - | - |
| 2022 Q3 | - | - | - | - |
| 2022 Q2 | 1 283.26 € | 129.83 € | - | - |
| 2022 Q1 | 1 365 € | 151.35 € | - | - |
| 2021 Q4 | 2 383.89 € | 314.2 € | - | - |
| 2021 Q3 | 2 681.47 € | 134.1 € | - | - |
| 2021 Q2 | 1 108.45 € | 78.65 € | - | - |
| 2021 Q1 | 4 383.31 € | 627.94 € | - | - |
| 2020 Q4 | 997.88 € | 100 € | - | - |
| 2020 Q3 | 3 069.26 € | 375.64 € | - | - |
| 2020 Q2 | 3 240.24 € | 436.07 € | - | - |
| 2020 Q1 | 1 253.02 € | 137 € | - | - |
